{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:13:53Z","timestamp":1777396433047,"version":"3.51.4"},"reference-count":39,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,10,30]]},"DOI":"10.3233\/jad-180624","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T15:18:19Z","timestamp":1539098299000},"page":"743-750","source":"Crossref","is-referenced-by-count":7,"title":["The Association Between Frontotemporal Lobar Degeneration and Bullous Pemphigoid"],"prefix":"10.1177","volume":"66","author":[{"given":"Kasper","family":"Katisko","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine \u2013 Neurology, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Kokkonen","sequence":"additional","affiliation":[{"name":"PEDEGO Research Unit, Dermatology, University of Oulu, Oulu, Finland"},{"name":"Medical Research Center, Oulu University Hospital, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"Medical Research Center, Oulu University Hospital, Oulu, Finland"},{"name":"Research Unit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Hartikainen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine \u2013 Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Koivisto","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine \u2013 Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Helisalmi","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine \u2013 Neurology, University of Eastern Finland, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ville E.","family":"Korhonen","sequence":"additional","affiliation":[{"name":"Neurocenter, Neurosurgery, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merja","family":"Kokki","sequence":"additional","affiliation":[{"name":"Anesthesia and Operative Services, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Tuusa","sequence":"additional","affiliation":[{"name":"PEDEGO Research Unit, Dermatology, University of Oulu, Oulu, Finland"},{"name":"Medical Research Center, Oulu University Hospital, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine \u2013 Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eino","family":"Solje","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine \u2013 Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[{"name":"A.I. Virtanen Institute for Molecular Sciences, University of Eastern, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Tasanen","sequence":"additional","affiliation":[{"name":"PEDEGO Research Unit, Dermatology, University of Oulu, Oulu, Finland"},{"name":"Medical Research Center, Oulu University Hospital, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Remes","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine \u2013 Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Medical Research Center, Oulu University Hospital, Oulu, Finland"},{"name":"Research Unit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland"},{"name":"Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180624_ref1","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-180624_ref2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-180624_ref3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.3233\/JAD-180624_ref4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.3233\/JAD-180624_ref5","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1468-1331.2010.03028.x","article-title":"Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients","volume":"17","author":"Kaivorinne","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-180624_ref6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1468-1331.2008.02272.x","article-title":"Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration","volume":"16","author":"Kr\u00fcger","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-180624_ref7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2377-8-48","article-title":"Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland","volume":"8","author":"Kaivorinne","year":"2008","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-180624_ref8","doi-asserted-by":"crossref","unstructured":"Burberry A , Suzuki N , Wang J-Y , Moccia R (2016) Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med 8, 347ra93.","DOI":"10.1126\/scitranslmed.aaf6038"},{"key":"10.3233\/JAD-180624_ref9","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1038\/srep23204","article-title":"C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice","volume":"6","author":"Atanasio","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180624_ref10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1474-4422(14)70065-1","article-title":"Frontotemporal dementia and its subtypes: A genome-wide association study","volume":"13","author":"Ferrari","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180624_ref11","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1038\/s41598-017-06117-y","article-title":"Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target","volume":"7","author":"Borroni","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180624_ref12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: A population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.3233\/JAD-180624_ref13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000106574","article-title":"Neurological disorders in patients with bullous pemphigoid","volume":"215","author":"Cordel","year":"2007","journal-title":"Dermatology"},{"key":"10.3233\/JAD-180624_ref14","doi-asserted-by":"crossref","first-page":"37125","DOI":"10.1038\/srep37125","article-title":"Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study","volume":"6","author":"F\u00f6rsti","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180624_ref15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: A prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.3233\/JAD-180624_ref16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","article-title":"A population-based study of the association between bullous pemphigoid and neurologic disorders","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.3233\/JAD-180624_ref17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.3233\/JAD-180624_ref18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","article-title":"Update on the pathogenesis of bullous pemphigoid: An autoantibody-mediated blistering disease targeting collagen XVII","volume":"73","author":"Nishie","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.3233\/JAD-180624_ref19","doi-asserted-by":"crossref","first-page":"240570","DOI":"10.1155\/2013\/240570","article-title":"Collagen XVII: A shared antigen in neurodermatological interactions?","volume":"2013","author":"Sepp\u00e4nen","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.3233\/JAD-180624_ref20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/exd.13401","article-title":"Neurological and psychiatric associations in bullous pemphigoid\u2014more than skin deep?","volume":"26","author":"F\u00f6rsti","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.3233\/JAD-180624_ref21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0151-9638(06)70935-8","article-title":"[Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid]","volume":"133","author":"Foureur","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.3233\/JAD-180624_ref22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jid.2015.12.005","article-title":"Autoantibodies to collagen XVII are present in Parkinson\u2019s disease and localize to tyrosine-hydroxylase positive neurons","volume":"136","author":"Messingham","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.3233\/JAD-180624_ref23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased levels of the bullous pemphigoid BP180 autoantibody are associated with more severe dementia in Alzheimer\u2019s disease","volume":"137","author":"Kokkonen","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.3233\/JAD-180624_ref24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.3233\/JAD-180624_ref25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2133.2004.06082.x","article-title":"Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid","volume":"151","author":"Sakuma-Oyama","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.3233\/JAD-180624_ref26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: A systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.3233\/JAD-180624_ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2018.05.011","article-title":"Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers","volume":"321","author":"Katisko","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-180624_ref28","doi-asserted-by":"crossref","first-page":"e0131817","DOI":"10.1371\/journal.pone.0131817","article-title":"The phenotype of the C9ORF72 expansion carriers according to revised criteria for bvFTD","volume":"10","author":"Solje","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180624_ref29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.13189","article-title":"Increasing incidence of bullous pemphigoid in Northern Finland: A retrospective database study in Oulu University Hospital","volume":"171","author":"F\u00f6rsti","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.3233\/JAD-180624_ref30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13023-015-0278-x","article-title":"Prevalence of pemphigus and pemphigoid autoantibodies in the general population","volume":"10","author":"Pr\u00fc\u00dfmann","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.3233\/JAD-180624_ref31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: A 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.3233\/JAD-180624_ref32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.3233\/JAD-180624_ref33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/bjd.14538","article-title":"Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction","volume":"175","author":"Recke","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.3233\/JAD-180624_ref34","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: Results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.3233\/JAD-180624_ref35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/exd.12877","article-title":"One gene but different proteins and diseases: The complexity of dystonin and bullous pemphigoid antigen 1","volume":"25","author":"K\u00fcnzli","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.3233\/JAD-180624_ref36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0625.2001.100405.x","article-title":"Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule","volume":"10","author":"Hamada","year":"2001","journal-title":"Exp Dermatol"},{"key":"10.3233\/JAD-180624_ref37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/bjd.16249","article-title":"A possible association between BP230-type bullous pemphigoid and dementia: A report of two cases in elderly patients","volume":"178","author":"Zheng","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.3233\/JAD-180624_ref38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-170854","article-title":"Low prevalence of cancer in patients with frontotemporal lobar degeneration","volume":"62","author":"Katisko","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180624_ref39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/art.10886","article-title":"Age and sex differences in hip joint space among asymptomatic subjects without structural change: Implications for epidemiologic studies","volume":"48","author":"Lanyon","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:16Z","timestamp":1777370896000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180624"}},"subtitle":[],"editor":[{"given":"Luisa","family":"Benussi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":39,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-180624","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]}}}